Cargando…
A left atrial appendage thrombus that developed during prophylactic low‐dose dabigatran treatment resolved after switching to apixaban
We describe a case of atrial fibrillation in which an intracardiac thrombus that could not be prevented with “low‐dose” dabigatran treatment was resolved by switching to apixaban treatment. Thrombolysis using direct oral anticoagulants (DOACs) could be a therapeutic option for patients with intracar...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5412875/ https://www.ncbi.nlm.nih.gov/pubmed/28469881 http://dx.doi.org/10.1002/ccr3.933 |
_version_ | 1783233092625891328 |
---|---|
author | Koyama, Taku Otsuka, Yoritaka Kawahara, Masaaki Imoto, Yuki Nakamura, Keita Kodama, Sunao Noguchi, Hiroo |
author_facet | Koyama, Taku Otsuka, Yoritaka Kawahara, Masaaki Imoto, Yuki Nakamura, Keita Kodama, Sunao Noguchi, Hiroo |
author_sort | Koyama, Taku |
collection | PubMed |
description | We describe a case of atrial fibrillation in which an intracardiac thrombus that could not be prevented with “low‐dose” dabigatran treatment was resolved by switching to apixaban treatment. Thrombolysis using direct oral anticoagulants (DOACs) could be a therapeutic option for patients with intracardiac thrombi, although the efficacies of different DOACs seem to differ and need further examination. |
format | Online Article Text |
id | pubmed-5412875 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-54128752017-05-03 A left atrial appendage thrombus that developed during prophylactic low‐dose dabigatran treatment resolved after switching to apixaban Koyama, Taku Otsuka, Yoritaka Kawahara, Masaaki Imoto, Yuki Nakamura, Keita Kodama, Sunao Noguchi, Hiroo Clin Case Rep Case Reports We describe a case of atrial fibrillation in which an intracardiac thrombus that could not be prevented with “low‐dose” dabigatran treatment was resolved by switching to apixaban treatment. Thrombolysis using direct oral anticoagulants (DOACs) could be a therapeutic option for patients with intracardiac thrombi, although the efficacies of different DOACs seem to differ and need further examination. John Wiley and Sons Inc. 2017-03-31 /pmc/articles/PMC5412875/ /pubmed/28469881 http://dx.doi.org/10.1002/ccr3.933 Text en © 2017 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Reports Koyama, Taku Otsuka, Yoritaka Kawahara, Masaaki Imoto, Yuki Nakamura, Keita Kodama, Sunao Noguchi, Hiroo A left atrial appendage thrombus that developed during prophylactic low‐dose dabigatran treatment resolved after switching to apixaban |
title | A left atrial appendage thrombus that developed during prophylactic low‐dose dabigatran treatment resolved after switching to apixaban |
title_full | A left atrial appendage thrombus that developed during prophylactic low‐dose dabigatran treatment resolved after switching to apixaban |
title_fullStr | A left atrial appendage thrombus that developed during prophylactic low‐dose dabigatran treatment resolved after switching to apixaban |
title_full_unstemmed | A left atrial appendage thrombus that developed during prophylactic low‐dose dabigatran treatment resolved after switching to apixaban |
title_short | A left atrial appendage thrombus that developed during prophylactic low‐dose dabigatran treatment resolved after switching to apixaban |
title_sort | left atrial appendage thrombus that developed during prophylactic low‐dose dabigatran treatment resolved after switching to apixaban |
topic | Case Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5412875/ https://www.ncbi.nlm.nih.gov/pubmed/28469881 http://dx.doi.org/10.1002/ccr3.933 |
work_keys_str_mv | AT koyamataku aleftatrialappendagethrombusthatdevelopedduringprophylacticlowdosedabigatrantreatmentresolvedafterswitchingtoapixaban AT otsukayoritaka aleftatrialappendagethrombusthatdevelopedduringprophylacticlowdosedabigatrantreatmentresolvedafterswitchingtoapixaban AT kawaharamasaaki aleftatrialappendagethrombusthatdevelopedduringprophylacticlowdosedabigatrantreatmentresolvedafterswitchingtoapixaban AT imotoyuki aleftatrialappendagethrombusthatdevelopedduringprophylacticlowdosedabigatrantreatmentresolvedafterswitchingtoapixaban AT nakamurakeita aleftatrialappendagethrombusthatdevelopedduringprophylacticlowdosedabigatrantreatmentresolvedafterswitchingtoapixaban AT kodamasunao aleftatrialappendagethrombusthatdevelopedduringprophylacticlowdosedabigatrantreatmentresolvedafterswitchingtoapixaban AT noguchihiroo aleftatrialappendagethrombusthatdevelopedduringprophylacticlowdosedabigatrantreatmentresolvedafterswitchingtoapixaban AT koyamataku leftatrialappendagethrombusthatdevelopedduringprophylacticlowdosedabigatrantreatmentresolvedafterswitchingtoapixaban AT otsukayoritaka leftatrialappendagethrombusthatdevelopedduringprophylacticlowdosedabigatrantreatmentresolvedafterswitchingtoapixaban AT kawaharamasaaki leftatrialappendagethrombusthatdevelopedduringprophylacticlowdosedabigatrantreatmentresolvedafterswitchingtoapixaban AT imotoyuki leftatrialappendagethrombusthatdevelopedduringprophylacticlowdosedabigatrantreatmentresolvedafterswitchingtoapixaban AT nakamurakeita leftatrialappendagethrombusthatdevelopedduringprophylacticlowdosedabigatrantreatmentresolvedafterswitchingtoapixaban AT kodamasunao leftatrialappendagethrombusthatdevelopedduringprophylacticlowdosedabigatrantreatmentresolvedafterswitchingtoapixaban AT noguchihiroo leftatrialappendagethrombusthatdevelopedduringprophylacticlowdosedabigatrantreatmentresolvedafterswitchingtoapixaban |